In addition, a previous report has shown that ERK1/2 activation is detected in glioblastoma multiforme and in peritumor tissues, which suggests that the ERK1/2 pathway may participate in GBM growth, tumor invasion, and progression [51]. This evidence concerns the gene MAPK3 and glioblastoma.